Primary experimental recordNegative / threshold

PMC13133793::ACT044553

LCKLSL

Evidence text

Paper-level observation

TUNEL assays revealed comparable apoptotic rates between LCKLSL-treated and control group (p>0.05) (Figure 4C and D), confirming the non-cytotoxic profile of LCKLSL within the experimental dose range.

textConfidence: medium

Assay observation

Activity

Toxicity

Subtype

Cytotoxic

Measure

cell_viability

Comparator

Raw observation

comparable apoptotic rates between LCKLSL-treated and control group (p>0.05)

Normalized measurement

>0.05

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

HUVEC

Assay method

Not reported by source

Sequence

LCKLSL

Standardization

ready simple

Source publication

Study on the Role of Short Peptide LCKLSL Targeting ANXA2 in Retinal Neovascularization.

In Vivo · 2026

DOI 10.21873/invivo.14291 PMC13133793

Parent mention

Related peptide identities

PEPDIA-PLP-001707

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.